He describes the data, and walks us through two different dosing strategies. Plus, the business case for this simple biologic, and thinking about other antigens and cancer types.
View all episodes
By BiotechTV
4.3
66 ratings
He describes the data, and walks us through two different dosing strategies. Plus, the business case for this simple biologic, and thinking about other antigens and cancer types.
3,374 Listeners
426 Listeners
1,644 Listeners
938 Listeners
125 Listeners
321 Listeners
213 Listeners
6,444 Listeners
61 Listeners
9,855 Listeners
86 Listeners
34 Listeners
19 Listeners
0 Listeners
4 Listeners
2 Listeners
5 Listeners
49 Listeners